Medico Remedies Complete Financial Statements
In FY2026, Medico Remedies (MEDICO) reported revenue ₹206 Cr, net profit ₹13 Cr and EPS ₹1.58, with a net profit margin of 6.3% and ROE of 17.1%. Full financial statements from FY2015 to FY2026 (12 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. Review MEDICO PE ratio trends to evaluate earnings-based valuation against sector peers.
Complete Financial Data Export
Profitability Ratios
Balance Sheet Ratios
MEDICO Revenue, Net Profit & EBITDA — Year-on-Year Growth
MEDICO YoY (March 2025 vs March 2026) — revenue +33.8%, net profit +30.0%, EBITDA -5.6%, expenses +39.0%. Explore Medico Remedies intrinsic worth to estimate fundamental worth using multiple valuation models.
MEDICO Income Statement — Revenue, EBITDA & Net Profit
Medico Remedies revenue ₹206 Cr, EBITDA ₹17 Cr, net profit ₹13 Cr, EPS ₹1.58 (2026) — net profit margin 6.3%. For live price, earnings ratios and company overview, see Medico Remedies share price screener.
| Particulars | March 2026 | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 206 | 154 | 147 | 144 | 123 | 123 | 91 | 100 | 62 | 55 | 67 | 51 |
| Expenses | 189 | 136 | 132 | 131 | 114 | 117 | 86 | 95 | 58 | 50 | 63 | 48 |
| EBITDA | 17 | 18 | 15 | 14 | 9 | 6 | 5 | 5 | 4 | 4 | 4 | 3 |
| Operating Profit Margin % | 8.00% | 10.00% | 9.00% | 7.00% | 6.00% | 4.00% | 3.00% | 3.00% | 6.00% | 7.00% | 5.00% | 6.00% |
| Depreciation | 3 | 3 | 3 | 3 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 |
| Interest | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 |
| Profit Before Tax | 18 | 14 | 11 | 10 | 7 | 4 | 2 | 2 | 2 | 2 | 2 | 1 |
| Tax | 5 | 3 | 3 | 3 | 2 | 1 | 1 | 1 | 1 | 0 | 1 | 0 |
| Net Profit | 13 | 10 | 8 | 7 | 5 | 3 | 2 | 2 | 1 | 2 | 1 | 1 |
| Earnings Per Share (₹) | 1.58 | 1.22 | 1.00 | 0.87 | 0.58 | 1.56 | 3.93 | 3.78 | 3.65 | 5.09 | 3.53 | 5.91 |
MEDICO Balance Sheet — Assets, Liabilities & Shareholders' Equity
MEDICO total assets ₹153 Cr, total equity ₹76 Cr, total liabilities ₹ Cr (2026) — ROE 17.1%.
| Particulars | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| Total Assets | 153 | 120 | 96 | 87 | 77 | 76 | 75 | 76 | 59 | 48 | 46 | 36 |
| Current Assets | 129 | 97 | 74 | 65 | 58 | 59 | 57 | 59 | 46 | 38 | 37 | 26 |
| Fixed Assets | 23 | 21 | 22 | 22 | 18 | 15 | 13 | 12 | 7 | 7 | 7 | 8 |
| Capital Work in Progress | 3 | 0 | 0 | 0 | 0 | 0 | 2 | 1 | 4 | 3 | 0 | 0 |
| Investments | 30 | 2 | 2 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 0 | 97 | 73 | 64 | 59 | 59 | 60 | 63 | 48 | 39 | 39 | 28 |
| LIABILITIES | ||||||||||||
| Total Liabilities | ||||||||||||
| Current Liabilities | 0 | 0 | 1 | 2 | 3 | 5 | 5 | 3 | 3 | 11 | 4 | 1 |
| Non-Current Liabilities | ||||||||||||
| SHAREHOLDERS' EQUITY | ||||||||||||
| Total Equity | 76 | 63 | 52 | 44 | 37 | 33 | 30 | 28 | 27 | 16 | 15 | 14 |
| Share Capital | 17 | 17 | 17 | 17 | 17 | 4 | 4 | 4 | 4 | 3 | 2 | 2 |
| Reserves & Surplus | 59 | 46 | 36 | 27 | 20 | 28 | 26 | 24 | 23 | 13 | 13 | 12 |
MEDICO Cash Flow Statement — Operating, Investing & Financing
Medico Remedies operating cash flow ₹5 Cr, investing ₹-4 Cr, financing ₹-1 Cr, net cash flow ₹1 Cr (2025).
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 5 | 2 | 8 | 6 | -11 | 1 | 5 | 5 | -3 | -4 | 0 |
| Investing Activities | -4 | -3 | -7 | -2 | -17 | -3 | -4 | -5 | -3 | 0 | -2 |
| Financing Activities | -1 | -1 | -2 | -6 | 18 | 3 | -1 | -1 | 6 | 2 | 3 |
| Net Cash Flow | 1 | -1 | 0 | -2 | -10 | 1 | 0 | -1 | 0 | -1 | 1 |